IBDEI0CX ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6153,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6153,1,4,0)
 ;;=4^493.90
 ;;^UTILITY(U,$J,358.3,6153,1,5,0)
 ;;=5^Asthma NOS
 ;;^UTILITY(U,$J,358.3,6153,2)
 ;;=^330091
 ;;^UTILITY(U,$J,358.3,6154,0)
 ;;=724.5^^41^497^16
 ;;^UTILITY(U,$J,358.3,6154,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6154,1,4,0)
 ;;=4^724.5
 ;;^UTILITY(U,$J,358.3,6154,1,5,0)
 ;;=5^Back Pain, Chronic
 ;;^UTILITY(U,$J,358.3,6154,2)
 ;;=^12250
 ;;^UTILITY(U,$J,358.3,6155,0)
 ;;=600.00^^41^497^14
 ;;^UTILITY(U,$J,358.3,6155,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6155,1,4,0)
 ;;=4^600.00
 ;;^UTILITY(U,$J,358.3,6155,1,5,0)
 ;;=5^BPH w/o Obstruction
 ;;^UTILITY(U,$J,358.3,6155,2)
 ;;=^334276
 ;;^UTILITY(U,$J,358.3,6156,0)
 ;;=490.^^41^497^18
 ;;^UTILITY(U,$J,358.3,6156,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6156,1,4,0)
 ;;=4^490.
 ;;^UTILITY(U,$J,358.3,6156,1,5,0)
 ;;=5^Bronchitis NOS
 ;;^UTILITY(U,$J,358.3,6156,2)
 ;;=^17164
 ;;^UTILITY(U,$J,358.3,6157,0)
 ;;=682.8^^41^497^21
 ;;^UTILITY(U,$J,358.3,6157,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6157,1,4,0)
 ;;=4^682.8
 ;;^UTILITY(U,$J,358.3,6157,1,5,0)
 ;;=5^Cellulitis NEC
 ;;^UTILITY(U,$J,358.3,6157,2)
 ;;=^271896
 ;;^UTILITY(U,$J,358.3,6158,0)
 ;;=585.9^^41^497^22
 ;;^UTILITY(U,$J,358.3,6158,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6158,1,4,0)
 ;;=4^585.9
 ;;^UTILITY(U,$J,358.3,6158,1,5,0)
 ;;=5^Chronic Renal Insufficiency
 ;;^UTILITY(U,$J,358.3,6158,2)
 ;;=^332812
 ;;^UTILITY(U,$J,358.3,6159,0)
 ;;=428.0^^41^497^19
 ;;^UTILITY(U,$J,358.3,6159,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6159,1,4,0)
 ;;=4^428.0
 ;;^UTILITY(U,$J,358.3,6159,1,5,0)
 ;;=5^CHF
 ;;^UTILITY(U,$J,358.3,6159,2)
 ;;=^54758
 ;;^UTILITY(U,$J,358.3,6160,0)
 ;;=496.^^41^497^20
 ;;^UTILITY(U,$J,358.3,6160,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6160,1,4,0)
 ;;=4^496.
 ;;^UTILITY(U,$J,358.3,6160,1,5,0)
 ;;=5^COPD
 ;;^UTILITY(U,$J,358.3,6160,2)
 ;;=^24355
 ;;^UTILITY(U,$J,358.3,6161,0)
 ;;=414.01^^41^497^23
 ;;^UTILITY(U,$J,358.3,6161,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6161,1,4,0)
 ;;=4^414.01
 ;;^UTILITY(U,$J,358.3,6161,1,5,0)
 ;;=5^Coronary Artery Disease
 ;;^UTILITY(U,$J,358.3,6161,2)
 ;;=^303281
 ;;^UTILITY(U,$J,358.3,6162,0)
 ;;=311.^^41^497^25
 ;;^UTILITY(U,$J,358.3,6162,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6162,1,4,0)
 ;;=4^311.
 ;;^UTILITY(U,$J,358.3,6162,1,5,0)
 ;;=5^Depression
 ;;^UTILITY(U,$J,358.3,6162,2)
 ;;=^35603
 ;;^UTILITY(U,$J,358.3,6163,0)
 ;;=250.01^^41^497^26
 ;;^UTILITY(U,$J,358.3,6163,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6163,1,4,0)
 ;;=4^250.01
 ;;^UTILITY(U,$J,358.3,6163,1,5,0)
 ;;=5^Diabetes, Type 1
 ;;^UTILITY(U,$J,358.3,6163,2)
 ;;=^331780
 ;;^UTILITY(U,$J,358.3,6164,0)
 ;;=250.00^^41^497^27
 ;;^UTILITY(U,$J,358.3,6164,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6164,1,4,0)
 ;;=4^250.00
 ;;^UTILITY(U,$J,358.3,6164,1,5,0)
 ;;=5^Diabetes, Type 2
 ;;^UTILITY(U,$J,358.3,6164,2)
 ;;=^331779
 ;;^UTILITY(U,$J,358.3,6165,0)
 ;;=305.90^^41^497^29
 ;;^UTILITY(U,$J,358.3,6165,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6165,1,4,0)
 ;;=4^305.90
 ;;^UTILITY(U,$J,358.3,6165,1,5,0)
 ;;=5^Drug Abuse-Unspec
 ;;^UTILITY(U,$J,358.3,6165,2)
 ;;=^268258
 ;;^UTILITY(U,$J,358.3,6166,0)
 ;;=305.93^^41^497^28
 ;;^UTILITY(U,$J,358.3,6166,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6166,1,4,0)
 ;;=4^305.93
 ;;^UTILITY(U,$J,358.3,6166,1,5,0)
 ;;=5^Drug Abuse-In Remission
 ;;^UTILITY(U,$J,358.3,6166,2)
 ;;=^268261
 ;;^UTILITY(U,$J,358.3,6167,0)
 ;;=796.2^^41^497^33
 ;;^UTILITY(U,$J,358.3,6167,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6167,1,4,0)
 ;;=4^796.2
